| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MSH5-SAPCD1 readthrough (NMD candidate) | 0.760 | 0.423 |
|
disease | 0.100 | None | 1.000 | 3 | 1 | 2008 | 2012 | |||||||||
|
ATP6V1G2-DDX39B readthrough (NMD candidate) | 0.769 | 0.423 |
|
disease | 0.100 | None | 1.000 | 3 | 8 | 2007 | 2011 | |||||||||
|
PPT2-EGFL8 readthrough (NMD candidate) | 0.792 | 0.462 |
|
disease | 0.100 | None | 1.000 | 3 | 6 | 2007 | 2011 | |||||||||
|
ADIPOQ antisense RNA 1 | 1.000 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2009 | 2017 | |||||||||
|
IFNG antisense RNA 1 | 0.659 | 0.654 |
|
disease | 0.110 | None | 1.000 | 3 | 3 | 2009 | 2017 | |||||||||
|
T helper type 2 locus control region associated RNA | 0.751 | 0.385 |
|
disease | 0.100 | None | 1.000 | 3 | 2 | 2009 | 2015 | |||||||||
|
IL12A antisense RNA 1 | 0.633 | 0.654 |
|
disease | 0.100 | None | 1.000 | 3 | 4 | 2008 | 2016 | |||||||||
|
TSBP1 and BTNL2 antisense RNA 1 | 0.638 | 0.692 |
|
disease | 0.100 | None | 1.000 | 3 | 68 | 2008 | 2016 | |||||||||
|
TSBP1 and BTNL2 antisense RNA 1 | 0.638 | 0.692 |
|
disease | 0.100 | None | 1.000 | 3 | 3 | 2010 | 2012 | |||||||||
|
C2 antisense RNA 1 | 0.821 | 0.192 |
|
disease | 0.100 | None | 1.000 | 3 | 5 | 2007 | 2011 | |||||||||
|
long intergenic non-protein coding RNA 2341 | 0.751 | 0.231 |
|
phenotype | 0.100 | None | 1.000 | 3 | 58 | 2008 | 2018 | |||||||||
|
EHMT2 and SLC44A4 antisense RNA 1 | 0.780 | 0.462 |
|
disease | 0.100 | None | 1.000 | 3 | 4 | 2007 | 2011 | |||||||||
|
NRXN2 antisense RNA 1 | 0.931 | 0.115 |
|
disease | 0.100 | None | 1.000 | 3 | 9 | 2010 | 2013 | |||||||||
|
NRXN2 antisense RNA 1 | 0.931 | 0.115 |
|
disease | 0.100 | None | 1.000 | 3 | 9 | 2010 | 2013 | |||||||||
|
SLCO1B3-SLCO1B7 readthrough | 0.839 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 3 | 13 | 2009 | 2019 | |||||||||
|
SLCO1B3-SLCO1B7 readthrough | 0.839 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 3 | 13 | 2009 | 2013 | |||||||||
|
C-reactive protein pseudogene 1 |
|
phenotype | 0.100 | None | 1.000 | 3 | 1 | 2012 | 2019 | |||||||||||
|
AFG3 like matrix AAA peptidase subunit 1, pseudogene | 0.931 | 0.115 |
|
disease | 0.100 | None | 1.000 | 3 | 6 | 2009 | 2017 | |||||||||
|
major histocompatibility complex, class I, S (pseudogene) | 0.931 | 0.192 |
|
disease | 0.100 | None | 1.000 | 3 | 1 | 2007 | 2011 | |||||||||
|
HNF1A antisense RNA 1 | 0.621 | 0.538 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2009 | 2019 | |||||||||
|
HNF1A antisense RNA 1 | 0.621 | 0.538 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2009 | 2013 | |||||||||
|
HNF1A antisense RNA 1 | 0.621 | 0.538 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2010 | 2018 | |||||||||
|
major histocompatibility complex, class II, DR beta 9 (pseudogene) | 0.682 | 0.654 |
|
disease | 0.100 | None | 1.000 | 3 | 3 | 2011 | 2019 | |||||||||
|
immunity related GTPase M | 0.617 | 0.538 |
|
disease | 0.700 | None | 0.939 | 3 | 3 | 2007 | 2020 | |||||||||
|
H2A clustered histone 9, pseudogene | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 3 | 1 | 2008 | 2009 |